Scientific Online Resource System

Heart - Lung (Varna)

History of foam sclerotherapy—a review

Angel Angelov, Emil Jordanov, Georgi Angelov, Veselin Petrov

Abstract

Introduction: Primary varicose veins of the lower extremities mainly cover the great saphenous vein (VSM) and small saphenous vein (VSP) basins. The treatment procedure for pulse removal can be performed by a standard open technique—crossectomy and stripping, by minimally invasive methods—radiofrequency and laser ablation, as well as by internal application of a sclerosing agent in liquid or foam format. The use of foam began as far back as 1939.

Literature Review: This publication examines in detail the historical stages that foam sclerotherapy has gone through from its inception to the present day. The rules for treatment with sclerosing high-viscosity foam, approved by phlebologists worldwide, are described in detail.

Discussion: Foam sclerotherapy for various forms of varicose veins is a uniquely good and inexpensive method for radical treatment of superficial varicose veins. Even if the recurrence rate after foam sclerotherapy is slightly higher than other minimally invasive procedures, foam treatment is an affordable, inexpensive, and highly effective method, as long as it is performed according to the accepted rules.

Conclusion: The present material considers the individual historical moments for establishing the foam treatment as a method of choice. John Bergan’s 2003 statement: “Foam is the future of varicose vein treatment,” is still relevant today.


Keywords

foam sclerotherapy, historical aspects, chemical ablation

Full Text


References

Angelov A, Endovenous laser ablation of trunk varicose veins. Monography. Medical University -Varna, 2019, 65-70, 84-88, 121-125

Barber F, Baker D, Nation A et al: Ultrasonic duplex echo-Doppler scanner. IEEE Trans. Biomed Eng 1974; 21: 109.

Breu FX, Guggenbichler S, Wollmann JC, 2nd European Consensus Meeting on Foam Sclerotherapy, 28-30 April 2006, Tegernsee, Germany. Vasa 2008, 37(71): 1-32.

Cabrera Carrido J, Cabrerea Garcia-Olmedo J, Injectable micro foam containing a sclerosant agent. European Patent Office, EP 656203A1; 21.06.1994.

Cunningham CJ, Method and apparatus for producing foam, European Patent Office, EP 11381A, 16.10.1979

Durant TM, Stauffer HM, Oppenheimer MJ, Paul RE, Safety of intravascular carbon dioxide and the use for roentgenology visualization of intracardiac structures. Ann Int Med, 1957; 47:191-201.

Flückiger P. Beitrag zur Technik der ambulanten Varizenbehandlung. Die med Welt 1963; 12:617-621.

Flückiger P. Nicht-operative retrograde Varizenverödung mit Varsylschaum. Schweiz Med Wochenschr 1956; 48:1368-1370.

Foote RR, The injection treatment. London: HK Lews&Co. Ltd., 1944; 13-44.

Gillesberger W. Die Ausrüstung der phlebologisch tätigen Dermatologen. Z Hautkrankheiten 1969; 44:669-674.

Hess H. Digitale Subtraktionsangiographie mit Kohlendioxid: eine Alternative zur Extremitätenangiographie mit jodhaltigen Kontrastmitteln. Fortschr Röntgenstr. 1990;153:233-238.

Harman AD Harper PV, Pollock N, Sinclair GS, Generation of therapeutic microfoam, European Patent Office EP 13372338B1; 23.11.2001.

Hauer G. German Patent DE 34 17 182 C2. Zwillings-Spritzen-Set. 1984.

Hübner K, Praktische Sklerotherapie, 2008, 142-160, 164-185.

Knight RM, Vin F, Zygmunt JA, Ultrasonic guidance of injection into the superficial venous system, Phlebology 1989; 339-341.

Kressler: Fachinformation Aethoxysklerol 0,25%, 0,5 %, 1 %, 2 % und 3 %; Stand Oktober 2009, Chemische Fabrik Kreussler & Co GmbH.

Mayer H, Brücke H. Angiologie - Zur Ätiologie und Behandlung der Varizen der Unteren Extremitäten. Chir Prax 1957; 4:521-528.

McAusland S. The modern treatment of varicose vein. Med Press Circular 1939; 201: 404-410.

Monfreux A. Traitement sclerosant des troncs sapheniens et leurs collaterals de gros calibre par la methode mus. Phlebology 1997; 50:351-353.

Orbach EJ, Sclerotherapy of varicose veins – Utilization of an intravenous air block. Am J Surg 1944; LXVI(3): 362-366.

Orbach EJ, Petretti AK. The thrombogenic property of foam of a synthetic anionic detergent. Angiol 1950; 1:237-243.

Orbach EJ, Contributions to the therapy of varicose complex. J INT College Surgeons 1950; 6:765-771.

Poizot E, Device for producing foam, European Patent Office, EP 379818A1, 21.12.1989.

Rabe E, Otto J, Schliephake D, Pannier F Efficacy and safety of great saphenous vein sclerotherapy using standardized polidocanol foam (ESAF): A randomized controlled multicenter clinical trial. Eur J Endovasc Vasc Surg 2008; 35:2238-2245.

Rabe E, Pannier F, Gerlach F, Breu FX., Guggenbichler S., Wollmann JC., Leitlinie Sklerosierungsbehandlung der Varikose, Phlebologie 2008; 37:27-34.

Rabe E, Pannier-Fischer F, Gerlach F. et al. Guidelines for sclerotherapy of varicose veins. Dermatol Surg 2004; 30:687-693.

Rabe E, Schliephake D, Otto J, Breu FX, Pannier F: Sclerotherapy of telangiectasis and reticular veins : a double-blind, randomized comparative clinical trial of polidocanol, solidum tetradecyl sulphate and isotonic saline (EASI study). Phlebology 2010; 25:124-131.

Rabe E, Gerlach F, Breu FX, Guggenbichler S, Stücker M, Pannier F, Leitlinie: Sklerosierungsbehandlung der Varikose, Phlebologie 2012; 4:3-10.

Ree A. Etamolin foam in the treatment of varicose veins. A new method. Acta Dermatovenerol. 1953; 33:435-436.

Sadoun S, Benigni JP, The treatment of varicosities and telangiectases with TDS or lauromacrogol foam: video tape: UIP World Congress of Phlebology, Sydney, 1998.

Schadeck M. Echosclerose de la grande Saphene. Phlebologie 1993;46:673-682.

Sigg K, Neuere Gesichtspunkte zur Technik der Varizenbehandlung. Ther Umsch 1949; 6:127-134.

Stemmer R, Kopp C, Voglet F, Physikalische Studie der Sklerosierungsinjektion, Zentralbl Phlebol 1970; 9(2): 112-123.

Tessari L, Cavezzi A, Frullini A, Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27:58-60.

Waldschmidt E, Device for producing foam. Unite States Patent Office, US 2043599A, 09.06.1936

Wildenhues B. Catheter assisted foam sclerotherapy: A new minimally invasive method for the treatment of the trunk varicose of the long and short saphenous veins. Phlebology 2005; 34:165-170.

Willsmann H. Schaumbestimmung von Tensiden mit einer Reibschaummethode. Fette, Seifen, Anstrichmittel, 1964,66,11, 955-961

Wollmann JC, Die Geschichte der Sclerosierungsschäume, Praktische Sklerotherapie, 2008, 142-149.

Wollmann JC, Herstellung und Eigenschaften von Sklerosierungsschaum, Vasomed 2004; 16,1:24.

Wollmann JC, Schaum – zwischen Vergangenheit und Zukunft, Vasomed 2002; 16:34-35.

Wollmann JC, The history of sclerosing foams, Dermatol Surg 2004; 30:694-703.




DOI: http://dx.doi.org/10.14748/hl.v25i1.8398

Refbacks

Font Size


|